Navigation Links
Max Neeman International ISO 27001:2005 Certified for Information Security Management Systems
Date:1/5/2011

RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2011 /PRNewswire/ -- Max Neeman announces the grant of ISO 27001:2005 certificate; one of only a few Indian CROs to be certified for Information Security.  

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

This updated certification of the world renowned British Standard for Information Security Management Systems (BS 7799-2:2002) is the standard outlining requirements for an Information Security Management System (ISMS). An ISMS helps in designing; implementing and maintaining a set of processes and systems to manage the risk posed to the information assets of an organization. Thus, helps in achieving the standards of – confidentiality, integrity and availability necessary for information security.

India is the hub of outsourced clinical research and this growth can be impeded by the threat posed to the security of the data generated in the trials. Sponsor companies have been seen to be apprehensive about information security.  

Max Neeman is involved in the development of various novel research molecules and handles crucial information related to the development of these molecules. ISO 27001 certification assures that the systems, processes and controls are rigorous to protect the integrity and confidentiality of information.  The certification helps Max Neeman in assuring the clients on integrity and confidentiality of the data generated in clinical research.  

The ISO 27001:2005 certification Max Neeman has achieved, assures that systems, processes and controls are stringent and sound enough to protect the integrity and confidentiality of information. Max Neeman is in par with all the other global Contract Research Organizations and in meeting global standards.

About Max Neeman International

Max Neeman International is a leading India-based CRO. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in over 31 cities with 6 regional offices.  Contact Donald Swankie, Vice President of Business Development via email to donald.swankie@neeman-medical.com or call +1.919.424.3345.  For more information please visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
2. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
3. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
4. Max Neeman International and AMEDON Collaborate to Increase EDC Performance
5. Max Neeman International Expands Specialized Surgical Team for Clinical Trials
6. Transposagen and Cellular Dynamics International Cross-License Technologies for Induced Pluripotent Stem Cells
7. Dongsheng Pharmaceutical International Co. Granted Exclusive Sales Rights for Thymosin Alpha 1 Injection
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
11. SRI International Completes Integration of Sarnoff Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Research and Markets has announced the addition of the ... to their offering. ... This research service on the global pharmaceutical stability testing market ... of the key participants in the market. The ... 2020. The market is expected to grow at a CAGR of ...
(Date:1/20/2017)... January 20, 2017 ... an Nothilfe   Die internationale humanitäre Stadt soll ... zu schaffen   Seine Hoheit Scheich ... VAE sowie Herrscher von Dubai , ... der Hilfe (International Humanitarian City IHC) zu verdreifachen, um ...
(Date:1/19/2017)... , Jan. 19, 2017 The ... 233.7 billion by 2025, according to a new ... is anticipated to be predominantly driven by high ... into the large-scale production of new and therapeutically ... influx of drugs at an unprecedented rate into ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... ... Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the gifts and ... author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He was a ... pastor for over fifteen years. He is a graduate of N.C. College of Theology ...
(Date:1/22/2017)... Frisco, TX (PRWEB) , ... January 22, 2017 , ... ... and provide slow results. Often the results of a simple test will take days ... review. Any Lab Test Now offers customers direct access to their lab tests, bypassing ...
(Date:1/21/2017)... MALO, FRANCE (PRWEB) , ... January 21, 2017 , ... ... of the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER ... East Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel Biocare™ dental implant ... media for its creos™ line of bone regenerative products. Specifically, the ... he utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. ...
(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
Breaking Medicine News(10 mins):